Acknowledgment

This work was supported by the National Natural Science Foundation of China (31371455, 31171318 to Dali Li, 81330049 to Mingyao Liu), the Science and Technology Commission of Shanghai Municipality (14140900300 to Dali Li).

Interest statement

The author(s) declare that they have no conflict of interest.

References

[1] Abifadel M., Varret M., Rabès J.P., Allard D., Ouguerram K., Devillers M., Cruaud C., Benjannet S., Wickham L., Erlich D., Derré A., Villéger L., Farnier M., Beucler I., Bruckert E., Chambaz J., Chanu B., Lecerf J.M., Luc G., Moulin P., Weissenbach J., Prat A., Krempf M., Junien C., Seidah N.G., Boileau C.. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003, 34: 154-156 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Mutations in PCSK9 cause autosomal dominant hypercholesterolemia&author=Abifadel M.&author=Varret M.&author=Rabès J.P.&author=Allard D.&author=Ouguerram K.&author=Devillers M.&author=Cruaud C.&author=Benjannet S.&author=Wickham L.&author=Erlich D.&author=Derré A.&author=Villéger L.&author=Farnier M.&author=Beucler I.&author=Bruckert E.&author=Chambaz J.&author=Chanu B.&author=Lecerf J.M.&author=Luc G.&author=Moulin P.&author=Weissenbach J.&author=Prat A.&author=Krempf M.&author=Junien C.&author=Seidah N.G.&author=Boileau C.&publication_year=2003&journal=Nat Genet&volume=34&pages=154-156

[2] Bakondi B., Lv W., Lu B., Jones M.K., Tsai Y., Kim K.J., Levy R., Akhtar A.A., Breunig J.J., Svendsen C.N., Wang S.. In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa. Mol Ther, 2016, 24: 556-563 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa&author=Bakondi B.&author=Lv W.&author=Lu B.&author=Jones M.K.&author=Tsai Y.&author=Kim K.J.&author=Levy R.&author=Akhtar A.A.&author=Breunig J.J.&author=Svendsen C.N.&author=Wang S.&publication_year=2016&journal=Mol Ther&volume=24&pages=556-563

[3] Bengtsson N.E., Hall J.K., Odom G.L., Phelps M.P., Andrus C.R., Hawkins R.D., Hauschka S.D., Chamberlain J.R., Chamberlain J.S.. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat Commun, 2017, 8: 14454 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy&author=Bengtsson N.E.&author=Hall J.K.&author=Odom G.L.&author=Phelps M.P.&author=Andrus C.R.&author=Hawkins R.D.&author=Hauschka S.D.&author=Chamberlain J.R.&author=Chamberlain J.S.&publication_year=2017&journal=Nat Commun&volume=8&pages=14454

[4] Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F.. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339: 819-823 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Multiplex genome engineering using CRISPR/Cas systems&author=Cong L.&author=Ran F.A.&author=Cox D.&author=Lin S.&author=Barretto R.&author=Habib N.&author=Hsu P.D.&author=Wu X.&author=Jiang W.&author=Marraffini L.A.&author=Zhang F.&publication_year=2013&journal=Science&volume=339&pages=819-823

[5] Cox D.B.T., Platt R.J., Zhang F.. Therapeutic genome editing: prospects and challenges. Nat Med, 2015, 21: 121-131 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Therapeutic genome editing: prospects and challenges&author=Cox D.B.T.&author=Platt R.J.&author=Zhang F.&publication_year=2015&journal=Nat Med&volume=21&pages=121-131

[6] Cyranoski D.. Chinese scientists to pioneer first human CRISPR trial. Nature, 2016, 535: 476-477 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Chinese scientists to pioneer first human CRISPR trial&author=Cyranoski D.&publication_year=2016&journal=Nature&volume=535&pages=476-477

[7] Dever D.P., Bak R.O., Reinisch A., Camarena J., Washington G., Nicolas C.E., Pavel-Dinu M., Saxena N., Wilkens A.B., Mantri S., Uchida N., Hendel A., Narla A., Majeti R., Weinberg K.I., Porteus M.H.. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature, 2016, 539: 384-389 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells&author=Dever D.P.&author=Bak R.O.&author=Reinisch A.&author=Camarena J.&author=Washington G.&author=Nicolas C.E.&author=Pavel-Dinu M.&author=Saxena N.&author=Wilkens A.B.&author=Mantri S.&author=Uchida N.&author=Hendel A.&author=Narla A.&author=Majeti R.&author=Weinberg K.I.&author=Porteus M.H.&publication_year=2016&journal=Nature&volume=539&pages=384-389

[8] DeWitt M.A., Magis W., Bray N.L., Wang T., Berman J.R., Urbinati F., Heo S.J., Mitros T., Mu?oz D.P., Boffelli D., Kohn D.B., Walters M.C., Carroll D., Martin D.I.K., Corn J.E.. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Sci Transl Med, 2016, 8: 360ra134-360ra134 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells&author=DeWitt M.A.&author=Magis W.&author=Bray N.L.&author=Wang T.&author=Berman J.R.&author=Urbinati F.&author=Heo S.J.&author=Mitros T.&author=Mu?oz D.P.&author=Boffelli D.&author=Kohn D.B.&author=Walters M.C.&author=Carroll D.&author=Martin D.I.K.&author=Corn J.E.&publication_year=2016&journal=Sci Transl Med&volume=8&pages=360ra134-360ra134

[9] Ding Q., Strong A., Patel K.M., Ng S.L., Gosis B.S., Regan S.N., Cowan C.A., Rader D.J., Musunuru K.. Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circul Res, 2014, 115: 488-492 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing&author=Ding Q.&author=Strong A.&author=Patel K.M.&author=Ng S.L.&author=Gosis B.S.&author=Regan S.N.&author=Cowan C.A.&author=Rader D.J.&author=Musunuru K.&publication_year=2014&journal=Circul Res&volume=115&pages=488-492

[10] Doudna J.A., Charpentier E.. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014, 346: 1258096-1258096 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=The new frontier of genome engineering with CRISPR-Cas9&author=Doudna J.A.&author=Charpentier E.&publication_year=2014&journal=Science&volume=346&pages=1258096-1258096

[11] Friedmann T., Roblin R.. Gene therapy for human genetic disease?. Science, 1972, 175: 949-955 CrossRef ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Gene therapy for human genetic disease?&author=Friedmann T.&author=Roblin R.&publication_year=1972&journal=Science&volume=175&pages=949-955

[12] Fu Y., Foden J.A., Khayter C., Maeder M.L., Reyon D., Joung J.K., Sander J.D.. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol, 2013, 31: 822-826 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells&author=Fu Y.&author=Foden J.A.&author=Khayter C.&author=Maeder M.L.&author=Reyon D.&author=Joung J.K.&author=Sander J.D.&publication_year=2013&journal=Nat Biotechnol&volume=31&pages=822-826

[13] Guan Y., Ma Y., Li Q., Sun Z., Ma L., Wu L., Wang L., Zeng L., Shao Y., Chen Y., Ma N., Lu W., Hu K., Han H., Yu Y., Huang Y., Liu M., Li D.. CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse. EMBO Mol Med, 2016, 8: 477-488 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse&author=Guan Y.&author=Ma Y.&author=Li Q.&author=Sun Z.&author=Ma L.&author=Wu L.&author=Wang L.&author=Zeng L.&author=Shao Y.&author=Chen Y.&author=Ma N.&author=Lu W.&author=Hu K.&author=Han H.&author=Yu Y.&author=Huang Y.&author=Liu M.&author=Li D.&publication_year=2016&journal=EMBO Mol Med&volume=8&pages=477-488

[14] Hsu P.D., Lander E.S., Zhang F.. Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014, 157: 1262-1278 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Development and applications of CRISPR-Cas9 for genome engineering&author=Hsu P.D.&author=Lander E.S.&author=Zhang F.&publication_year=2014&journal=Cell&volume=157&pages=1262-1278

[15] Kim D., Bae S., Park J., Kim E., Kim S., Yu H.R., Hwang J., Kim J.I., Kim J.S.. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Meth, 2015, 12: 237-243 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells&author=Kim D.&author=Bae S.&author=Park J.&author=Kim E.&author=Kim S.&author=Yu H.R.&author=Hwang J.&author=Kim J.I.&author=Kim J.S.&publication_year=2015&journal=Nat Meth&volume=12&pages=237-243

[16] Kim K., Park S.W., Kim J.H., Lee S.H., Kim D., Koo T., Kim K.E., Kim J.H., Kim J.S.. Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. Genome Res, 2017, 27: 419-426 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration&author=Kim K.&author=Park S.W.&author=Kim J.H.&author=Lee S.H.&author=Kim D.&author=Koo T.&author=Kim K.E.&author=Kim J.H.&author=Kim J.S.&publication_year=2017&journal=Genome Res&volume=27&pages=419-426

[17] Kotterman M.A., Schaffer D.V.. Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet, 2014, 15: 445-451 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Engineering adeno-associated viruses for clinical gene therapy&author=Kotterman M.A.&author=Schaffer D.V.&publication_year=2014&journal=Nat Rev Genet&volume=15&pages=445-451

[18] Kuscu C., Arslan S., Singh R., Thorpe J., Adli M.. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat Biotechnol, 2014, 32: 677-683 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease&author=Kuscu C.&author=Arslan S.&author=Singh R.&author=Thorpe J.&author=Adli M.&publication_year=2014&journal=Nat Biotechnol&volume=32&pages=677-683

[19] Li D., Qiu Z., Shao Y., Chen Y., Guan Y., Liu M., Li Y., Gao N., Wang L., Lu X., Zhao Y., Liu M.. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol, 2013, 31: 681-683 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Heritable gene targeting in the mouse and rat using a CRISPR-Cas system&author=Li D.&author=Qiu Z.&author=Shao Y.&author=Chen Y.&author=Guan Y.&author=Liu M.&author=Li Y.&author=Gao N.&author=Wang L.&author=Lu X.&author=Zhao Y.&author=Liu M.&publication_year=2013&journal=Nat Biotechnol&volume=31&pages=681-683

[20] Long C., Amoasii L., Mireault A.A., McAnally J.R., Li H., Sanchez-Ortiz E., Bhattacharyya S., Shelton J.M., Bassel-Duby R., Olson E.N.. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science, 2016, 351: 400-403 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy&author=Long C.&author=Amoasii L.&author=Mireault A.A.&author=McAnally J.R.&author=Li H.&author=Sanchez-Ortiz E.&author=Bhattacharyya S.&author=Shelton J.M.&author=Bassel-Duby R.&author=Olson E.N.&publication_year=2016&journal=Science&volume=351&pages=400-403

[21] Long C., McAnally J.R., Shelton J.M., Mireault A.A., Bassel-Duby R., Olson E.N.. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science, 2014, 345: 1184-1188 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA&author=Long C.&author=McAnally J.R.&author=Shelton J.M.&author=Mireault A.A.&author=Bassel-Duby R.&author=Olson E.N.&publication_year=2014&journal=Science&volume=345&pages=1184-1188

[22] Ma H., Tu L.C., Naseri A., Huisman M., Zhang S., Grunwald D., Pederson T.. Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow. Nat Biotechnol, 2016, 34: 528-530 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow&author=Ma H.&author=Tu L.C.&author=Naseri A.&author=Huisman M.&author=Zhang S.&author=Grunwald D.&author=Pederson T.&publication_year=2016&journal=Nat Biotechnol&volume=34&pages=528-530

[23] Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M.. RNA-guided human genome engineering via Cas9. Science, 2013, 339: 823-826 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=RNA-guided human genome engineering via Cas9&author=Mali P.&author=Yang L.&author=Esvelt K.M.&author=Aach J.&author=Guell M.&author=DiCarlo J.E.&author=Norville J.E.&author=Church G.M.&publication_year=2013&journal=Science&volume=339&pages=823-826

[24] Maruyama T., Dougan S.K., Truttmann M.C., Bilate A.M., Ingram J.R., Ploegh H.L.. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol, 2015, 33: 538-542 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining&author=Maruyama T.&author=Dougan S.K.&author=Truttmann M.C.&author=Bilate A.M.&author=Ingram J.R.&author=Ploegh H.L.&publication_year=2015&journal=Nat Biotechnol&volume=33&pages=538-542

[25] Naldini L.. Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet, 2011, 12: 301-315 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Ex vivo gene transfer and correction for cell-based therapies&author=Naldini L.&publication_year=2011&journal=Nat Rev Genet&volume=12&pages=301-315

[26] Nelson C.E., Hakim C.H., Ousterout D.G., Thakore P.I., Moreb E.A., Castellanos Rivera R.M., Madhavan S., Pan X., Ran F.A., Yan W.X., Asokan A., Zhang F., Duan D., Gersbach C.A.. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science, 2016, 351: 403-407 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy&author=Nelson C.E.&author=Hakim C.H.&author=Ousterout D.G.&author=Thakore P.I.&author=Moreb E.A.&author=Castellanos Rivera R.M.&author=Madhavan S.&author=Pan X.&author=Ran F.A.&author=Yan W.X.&author=Asokan A.&author=Zhang F.&author=Duan D.&author=Gersbach C.A.&publication_year=2016&journal=Science&volume=351&pages=403-407

[27] Nguyen T.H., Anegon I.. Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success. EMBO Mol Med, 2016, 8: 439-441 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success&author=Nguyen T.H.&author=Anegon I.&publication_year=2016&journal=EMBO Mol Med&volume=8&pages=439-441

[28] Nygaard S., Barzel A., Haft A., Major A., Finegold M., Kay M.A., Grompe M.. A universal system to select gene-modified hepatocytes in vivo. Sci Transl Med, 2016, 8: 342ra79-342ra79 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=A universal system to select gene-modified hepatocytes in vivo&author=Nygaard S.&author=Barzel A.&author=Haft A.&author=Major A.&author=Finegold M.&author=Kay M.A.&author=Grompe M.&publication_year=2016&journal=Sci Transl Med&volume=8&pages=342ra79-342ra79

[29] Ou Z., Niu X., He W., Chen Y., Song B., Xian Y., Fan D., Tang D., Sun X.. The combination of CRISPR/Cas9 and iPSC technologies in the gene therapy of human β-thalassemia in mice. Sci Rep, 2016, 6: 32463 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=The combination of CRISPR/Cas9 and iPSC technologies in the gene therapy of human β-thalassemia in mice&author=Ou Z.&author=Niu X.&author=He W.&author=Chen Y.&author=Song B.&author=Xian Y.&author=Fan D.&author=Tang D.&author=Sun X.&publication_year=2016&journal=Sci Rep&volume=6&pages=32463

[30] Pankowicz F.P., Barzi M., Legras X., Hubert L., Mi T., Tomolonis J.A., Ravishankar M., Sun Q., Yang D., Borowiak M., Sumazin P., Elsea S.H., Bissig-Choisat B., Bissig K.D.. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nat Commun, 2016, 7: 12642 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia&author=Pankowicz F.P.&author=Barzi M.&author=Legras X.&author=Hubert L.&author=Mi T.&author=Tomolonis J.A.&author=Ravishankar M.&author=Sun Q.&author=Yang D.&author=Borowiak M.&author=Sumazin P.&author=Elsea S.H.&author=Bissig-Choisat B.&author=Bissig K.D.&publication_year=2016&journal=Nat Commun&volume=7&pages=12642

[31] Park C.Y., Kim D.H., Son J.S., Sung J.J., Lee J., Bae S., Kim J.H., Kim D.W., Kim J.S.. Functional correction of large factor VIII Gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9. Cell Stem Cell, 2015, 17: 213-220 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Functional correction of large factor VIII Gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9&author=Park C.Y.&author=Kim D.H.&author=Son J.S.&author=Sung J.J.&author=Lee J.&author=Bae S.&author=Kim J.H.&author=Kim D.W.&author=Kim J.S.&publication_year=2015&journal=Cell Stem Cell&volume=17&pages=213-220

[32] Pattanayak V., Lin S., Guilinger J.P., Ma E., Doudna J.A., Liu D.R.. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol, 2013, 31: 839-843 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity&author=Pattanayak V.&author=Lin S.&author=Guilinger J.P.&author=Ma E.&author=Doudna J.A.&author=Liu D.R.&publication_year=2013&journal=Nat Biotechnol&volume=31&pages=839-843

[33] Prakash V., Moore M., Yá?ez-Mu?oz R.J.. Current progress in therapeutic gene editing for monogenic diseases. Mol Ther, 2016, 24: 465-474 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Current progress in therapeutic gene editing for monogenic diseases&author=Prakash V.&author=Moore M.&author=Yá?ez-Mu?oz R.J.&publication_year=2016&journal=Mol Ther&volume=24&pages=465-474

[34] Ran F.A., Cong L., Yan W.X., Scott D.A., Gootenberg J.S., Kriz A.J., Zetsche B., Shalem O., Wu X., Makarova K.S., Koonin E.V., Sharp P.A., Zhang F.. In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015, 520: 186-191 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo genome editing using Staphylococcus aureus Cas9&author=Ran F.A.&author=Cong L.&author=Yan W.X.&author=Scott D.A.&author=Gootenberg J.S.&author=Kriz A.J.&author=Zetsche B.&author=Shalem O.&author=Wu X.&author=Makarova K.S.&author=Koonin E.V.&author=Sharp P.A.&author=Zhang F.&publication_year=2015&journal=Nature&volume=520&pages=186-191

[35] Ran F.A., Hsu P.D., Lin C.Y., Gootenberg J.S., Konermann S., Trevino A.E., Scott D.A., Inoue A., Matoba S., Zhang Y., Zhang F.. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell, 2013, 154: 1380-1389 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity&author=Ran F.A.&author=Hsu P.D.&author=Lin C.Y.&author=Gootenberg J.S.&author=Konermann S.&author=Trevino A.E.&author=Scott D.A.&author=Inoue A.&author=Matoba S.&author=Zhang Y.&author=Zhang F.&publication_year=2013&journal=Cell&volume=154&pages=1380-1389

[36] Schwank G., Koo B.K., Sasselli V., Dekkers J.F., Heo I., Demircan T., Sasaki N., Boymans S., Cuppen E., van der Ent C.K., Nieuwenhuis E.E.S., Beekman J.M., Clevers H.. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell, 2013, 13: 653-658 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients&author=Schwank G.&author=Koo B.K.&author=Sasselli V.&author=Dekkers J.F.&author=Heo I.&author=Demircan T.&author=Sasaki N.&author=Boymans S.&author=Cuppen E.&author=van der Ent C.K.&author=Nieuwenhuis E.E.S.&author=Beekman J.M.&author=Clevers H.&publication_year=2013&journal=Cell Stem Cell&volume=13&pages=653-658

[37] Song J., Yang D., Xu J., Zhu T., Chen Y.E., Zhang J.. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nat Commun, 2016, 7: 10548 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency&author=Song J.&author=Yang D.&author=Xu J.&author=Zhu T.&author=Chen Y.E.&author=Zhang J.&publication_year=2016&journal=Nat Commun&volume=7&pages=10548

[38] Staahl B.T., Benekareddy M., Coulon-Bainier C., Banfal A.A., Floor S.N., Sabo J.K., Urnes C., Munares G.A., Ghosh A., Doudna J.A.. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat Biotechnol, 2017, : in press doi: 10.1038/nbt.3806 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes&author=Staahl B.T.&author=Benekareddy M.&author=Coulon-Bainier C.&author=Banfal A.A.&author=Floor S.N.&author=Sabo J.K.&author=Urnes C.&author=Munares G.A.&author=Ghosh A.&author=Doudna J.A.&publication_year=2017&journal=Nat Biotechnol&pages=in press doi: 10.1038/nbt.3806

[39] Suzuki K., Tsunekawa Y., Hernandez-Benitez R., Wu J., Zhu J., Kim E.J., Hatanaka F., Yamamoto M., Araoka T., Li Z., Kurita M., Hishida T., Li M., Aizawa E., Guo S., Chen S., Goebl A., Soligalla R.D., Qu J., Jiang T., Fu X., Jafari M., Esteban C.R., Berggren W.T., Lajara J., Nu?ez-Delicado E., Guillen P., Campistol J.M., Matsuzaki F., Liu G.H., Magistretti P., Zhang K., Callaway E.M., Zhang K., Belmonte J.C.I.. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature, 2016, 540: 144-149 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration&author=Suzuki K.&author=Tsunekawa Y.&author=Hernandez-Benitez R.&author=Wu J.&author=Zhu J.&author=Kim E.J.&author=Hatanaka F.&author=Yamamoto M.&author=Araoka T.&author=Li Z.&author=Kurita M.&author=Hishida T.&author=Li M.&author=Aizawa E.&author=Guo S.&author=Chen S.&author=Goebl A.&author=Soligalla R.D.&author=Qu J.&author=Jiang T.&author=Fu X.&author=Jafari M.&author=Esteban C.R.&author=Berggren W.T.&author=Lajara J.&author=Nu?ez-Delicado E.&author=Guillen P.&author=Campistol J.M.&author=Matsuzaki F.&author=Liu G.H.&author=Magistretti P.&author=Zhang K.&author=Callaway E.M.&author=Zhang K.&author=Belmonte J.C.I.&publication_year=2016&journal=Nature&volume=540&pages=144-149

[40] Tabebordbar M., Zhu K., Cheng J.K.W., Chew W.L., Widrick J.J., Yan W.X., Maesner C., Wu E.Y., Xiao R., Ran F.A., Cong L., Zhang F., Vandenberghe L.H., Church G.M., Wagers A.J.. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science, 2016, 351: 407-411 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=In vivo gene editing in dystrophic mouse muscle and muscle stem cells&author=Tabebordbar M.&author=Zhu K.&author=Cheng J.K.W.&author=Chew W.L.&author=Widrick J.J.&author=Yan W.X.&author=Maesner C.&author=Wu E.Y.&author=Xiao R.&author=Ran F.A.&author=Cong L.&author=Zhang F.&author=Vandenberghe L.H.&author=Church G.M.&author=Wagers A.J.&publication_year=2016&journal=Science&volume=351&pages=407-411

[41] Tsai S.Q., Zheng Z., Nguyen N.T., Liebers M., Topkar V.V., Thapar V., Wyvekens N., Khayter C., Iafrate A.J., Le L.P., Aryee M.J., Joung J.K.. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol, 2015, 33: 187-197 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases&author=Tsai S.Q.&author=Zheng Z.&author=Nguyen N.T.&author=Liebers M.&author=Topkar V.V.&author=Thapar V.&author=Wyvekens N.&author=Khayter C.&author=Iafrate A.J.&author=Le L.P.&author=Aryee M.J.&author=Joung J.K.&publication_year=2015&journal=Nat Biotechnol&volume=33&pages=187-197

[42] Wang C.X., Sather B.D., Wang X., Adair J., Khan I., Singh S., Lang S., Adams A., Curinga G., Kiem H.P., Miao C.H., Rawlings D.J., Torbett B.E.. Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells. Blood, 2014, 124: 913-923 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells&author=Wang C.X.&author=Sather B.D.&author=Wang X.&author=Adair J.&author=Khan I.&author=Singh S.&author=Lang S.&author=Adams A.&author=Curinga G.&author=Kiem H.P.&author=Miao C.H.&author=Rawlings D.J.&author=Torbett B.E.&publication_year=2014&journal=Blood&volume=124&pages=913-923

[43] Wang L., Shao Y., Guan Y., Li L., Wu L., Chen F., Liu M., Chen H., Ma Y., Ma X., Liu M., Li D.. Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci Rep, 2015, 5: 17517 CrossRef PubMed ADS Google Scholar http://scholar.google.com/scholar_lookup?title=Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos&author=Wang L.&author=Shao Y.&author=Guan Y.&author=Li L.&author=Wu L.&author=Chen F.&author=Liu M.&author=Chen H.&author=Ma Y.&author=Ma X.&author=Liu M.&author=Li D.&publication_year=2015&journal=Sci Rep&volume=5&pages=17517

[44] Wu X., Scott D.A., Kriz A.J., Chiu A.C., Hsu P.D., Dadon D.B., Cheng A.W., Trevino A.E., Konermann S., Chen S., Jaenisch R., Zhang F., Sharp P.A.. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol, 2014, 32: 670-676 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells&author=Wu X.&author=Scott D.A.&author=Kriz A.J.&author=Chiu A.C.&author=Hsu P.D.&author=Dadon D.B.&author=Cheng A.W.&author=Trevino A.E.&author=Konermann S.&author=Chen S.&author=Jaenisch R.&author=Zhang F.&author=Sharp P.A.&publication_year=2014&journal=Nat Biotechnol&volume=32&pages=670-676

[45] Wu Y., Liang D., Wang Y., Bai M., Tang W., Bao S., Yan Z., Li D., Li J.. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell, 2013, 13: 659-662 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Correction of a genetic disease in mouse via use of CRISPR-Cas9&author=Wu Y.&author=Liang D.&author=Wang Y.&author=Bai M.&author=Tang W.&author=Bao S.&author=Yan Z.&author=Li D.&author=Li J.&publication_year=2013&journal=Cell Stem Cell&volume=13&pages=659-662

[46] Wu Y., Zhou H., Fan X., Zhang Y., Zhang M., Wang Y., Xie Z., Bai M., Yin Q., Liang D., Tang W., Liao J., Zhou C., Liu W., Zhu P., Guo H., Pan H., Wu C., Shi H., Wu L., Tang F., Li J.. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells. Cell Res, 2015, 25: 67-79 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells&author=Wu Y.&author=Zhou H.&author=Fan X.&author=Zhang Y.&author=Zhang M.&author=Wang Y.&author=Xie Z.&author=Bai M.&author=Yin Q.&author=Liang D.&author=Tang W.&author=Liao J.&author=Zhou C.&author=Liu W.&author=Zhu P.&author=Guo H.&author=Pan H.&author=Wu C.&author=Shi H.&author=Wu L.&author=Tang F.&author=Li J.&publication_year=2015&journal=Cell Res&volume=25&pages=67-79

[47] Xie C., Zhang Y.P., Song L., Luo J., Qi W., Hu J., Lu D., Yang Z., Zhang J., Xiao J., Zhou B., Du J.L., Jing N., Liu Y., Wang Y., Li B.L., Song B.L., Yan Y.. Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome. Cell Res, 2016, 26: 1099-1111 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome&author=Xie C.&author=Zhang Y.P.&author=Song L.&author=Luo J.&author=Qi W.&author=Hu J.&author=Lu D.&author=Yang Z.&author=Zhang J.&author=Xiao J.&author=Zhou B.&author=Du J.L.&author=Jing N.&author=Liu Y.&author=Wang Y.&author=Li B.L.&author=Song B.L.&author=Yan Y.&publication_year=2016&journal=Cell Res&volume=26&pages=1099-1111

[48] Yang Y., Wang L., Bell P., McMenamin D., He Z., White J., Yu H., Xu C., Morizono H., Musunuru K., Batshaw M.L., Wilson J.M.. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat Biotechnol, 2016, 34: 334-338 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice&author=Yang Y.&author=Wang L.&author=Bell P.&author=McMenamin D.&author=He Z.&author=White J.&author=Yu H.&author=Xu C.&author=Morizono H.&author=Musunuru K.&author=Batshaw M.L.&author=Wilson J.M.&publication_year=2016&journal=Nat Biotechnol&volume=34&pages=334-338

[49] Yin H., Song C.Q., Dorkin J.R., Zhu L.J., Li Y., Wu Q., Park A., Yang J., Suresh S., Bizhanova A., Gupta A., Bolukbasi M.F., Walsh S., Bogorad R.L., Gao G., Weng Z., Dong Y., Koteliansky V., Wolfe S.A., Langer R., Xue W., Anderson D.G.. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol, 2016, 34: 328-333 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo&author=Yin H.&author=Song C.Q.&author=Dorkin J.R.&author=Zhu L.J.&author=Li Y.&author=Wu Q.&author=Park A.&author=Yang J.&author=Suresh S.&author=Bizhanova A.&author=Gupta A.&author=Bolukbasi M.F.&author=Walsh S.&author=Bogorad R.L.&author=Gao G.&author=Weng Z.&author=Dong Y.&author=Koteliansky V.&author=Wolfe S.A.&author=Langer R.&author=Xue W.&author=Anderson D.G.&publication_year=2016&journal=Nat Biotechnol&volume=34&pages=328-333

[50] Yin H., Xue W., Chen S., Bogorad R.L., Benedetti E., Grompe M., Koteliansky V., Sharp P.A., Jacks T., Anderson D.G.. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol, 2014, 32: 551-553 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype&author=Yin H.&author=Xue W.&author=Chen S.&author=Bogorad R.L.&author=Benedetti E.&author=Grompe M.&author=Koteliansky V.&author=Sharp P.A.&author=Jacks T.&author=Anderson D.G.&publication_year=2014&journal=Nat Biotechnol&volume=32&pages=551-553

[51] Zhang X.H., Tee L.Y., Wang X.G., Huang Q.S., Yang S.H.. Off-target effects in CRISPR/Cas9-mediated genome engineering. Mol Ther Nucleic Acids, 2015, 4: e264 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Off-target effects in CRISPR/Cas9-mediated genome engineering&author=Zhang X.H.&author=Tee L.Y.&author=Wang X.G.&author=Huang Q.S.&author=Yang S.H.&publication_year=2015&journal=Mol Ther Nucleic Acids&volume=4&pages=e264